{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:45:00Z","timestamp":1790729100987,"version":"4.1.0"},"reference-count":79,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81701606"],"award-info":[{"award-number":["81701606"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Sichuan provincial health and Family Planning Commission","award":["16PJ284"],"award-info":[{"award-number":["16PJ284"]}]},{"name":"Hubei Provincial Key Laboratory of Occurrence and Intervention of Rheumatic diseases","award":["OIR17002A"],"award-info":[{"award-number":["OIR17002A"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.autrev.2018.01.017","type":"journal-article","created":{"date-parts":[[2018,5,3]],"date-time":"2018-05-03T05:45:12Z","timestamp":1525326312000},"page":"665-673","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":89,"title":["Emerging role of IL-35 in inflammatory autoimmune diseases"],"prefix":"10.1016","volume":"17","author":[{"given":"Lin-Chong","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An-Fang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang-Dong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2018.01.017_bb0005","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1002\/eji.200737810","article-title":"IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells","volume":"37","author":"Niedbala","year":"2007","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2018.01.017_bb0010","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/ni.1952","article-title":"IL-35-mediated induction of a potent regulatory T cell population","volume":"11","author":"Collison","year":"2010","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2018.01.017_bb0015","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1128\/JVI.70.2.1143-1153.1996","article-title":"A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes","volume":"70","author":"Devergne","year":"1996","journal-title":"J Virol"},{"key":"10.1016\/j.autrev.2018.01.017_bb0020","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.4049\/jimmunol.146.9.3074","article-title":"Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells","volume":"146","author":"Wolf","year":"1991","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2018.01.017_bb0025","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.4049\/jimmunol.148.11.3433","article-title":"Cloning and expression of murine IL-12","volume":"148","author":"Schoenhaut","year":"1992","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2018.01.017_bb0030","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S1074-7613(00)00070-4","article-title":"Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12","volume":"13","author":"Oppmann","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2018.01.017_bb0035","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S1074-7613(02)00324-2","article-title":"IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells","volume":"16","author":"Pflanz","year":"2002","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2018.01.017_bb0040","doi-asserted-by":"crossref","first-page":"12041","DOI":"10.1073\/pnas.94.22.12041","article-title":"Epstein-Barr virus-induced gene 3 and the p35 subunit of interleukin 12 form a novel heterodimeric hematopoietin","volume":"94","author":"Devergne","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2018.01.017_bb0045","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1600-065X.2008.00704.x","article-title":"Interleukin-35: odd one out or part of the family?","volume":"226","author":"Collison","year":"2008","journal-title":"Immunol Rev"},{"key":"10.1016\/j.autrev.2018.01.017_bb0050","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/ni.2227","article-title":"The composition and signaling of the IL-35 receptor are unconventional","volume":"13","author":"Collison","year":"2012","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2018.01.017_bb0055","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s10753-016-0453-9","article-title":"Interleukin-35: a potential therapeutic agent for autoimmune diseases","volume":"40","author":"Guan","year":"2017","journal-title":"Inflammation"},{"key":"10.1016\/j.autrev.2018.01.017_bb0060","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nm.3554","article-title":"Interleukin-35 induces regulatory B cells that suppress autoimmune disease","volume":"20","author":"Wang","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2018.01.017_bb0065","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1007\/s13277-014-2887-8","article-title":"Elevated plasma interleukin-35 levels predict poor prognosis in patients with non-small cell lung cancer","volume":"36","author":"Gu","year":"2015","journal-title":"Tumour Biol"},{"key":"10.1016\/j.autrev.2018.01.017_bb0070","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.humimm.2013.09.018","article-title":"Circulating IL-35 in pancreatic ductal adenocarcinoma patients","volume":"75","author":"Jin","year":"2014","journal-title":"Hum Immunol"},{"key":"10.1016\/j.autrev.2018.01.017_bb0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0110126","article-title":"Mathematical modeling of interleukin-35 promoting tumor growth and angiogenesis","volume":"9","author":"Liao","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2018.01.017_bb0080","first-page":"1806","article-title":"Assessing the role of IL-35 in colorectal cancer progression and prognosis","volume":"6","author":"Zeng","year":"2013","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.autrev.2018.01.017_bb0085","doi-asserted-by":"crossref","first-page":"713","DOI":"10.3892\/ijmm.2016.2688","article-title":"Effects of an intravitreal injection of interleukin-35-expressing plasmid on pro-inflammatory and anti-inflammatory cytokines","volume":"38","author":"Hou","year":"2016","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.autrev.2018.01.017_bb0090","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1016\/j.celrep.2017.10.090","article-title":"Reciprocal expression of IL-35 and IL-10 defines two distinct effector Treg subsets that are required for maintenance of immune tolerance","volume":"21","author":"Wei","year":"2017","journal-title":"Cell Rep"},{"key":"10.1016\/j.autrev.2018.01.017_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0189617","article-title":"Interleukin-35 mitigates the function of murine transplanted islet cells via regulation of Treg\/Th17 ratio","volume":"12","author":"Zongyi","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2018.01.017_bb0100","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/sji.12613","article-title":"Mesenchymal stem cells overexpressing interleukin-35 propagate immunosuppressive effects in mice","volume":"86","author":"Guo","year":"2017","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.autrev.2018.01.017_bb0105","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3389\/fimmu.2017.00098","article-title":"Interleukin-35-producing CD8\u03b1+ dendritic cells acquire a tolerogenic state and regulate T cell function","volume":"8","author":"Haller","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2018.01.017_bb0110","article-title":"Lipopolysaccharide-induced M2 to M1 macrophage transformation for IL-12p70 production is blocked by Candida albicans mediated up-regulation of EBI3 expression","volume":"8","author":"Zheng","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2018.01.017_bb0115","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.1172\/JCI57582","article-title":"Renal collecting duct epithelial cells regulate inflammation in tubulointerstitial damage in mice","volume":"121","author":"Fujiu","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2018.01.017_bb0120","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nri3073","article-title":"Protective and pathogenic functions of macrophage subsets","volume":"11","author":"Murray","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2018.01.017_bb0125","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.4049\/jimmunol.1600446","article-title":"IL-35 decelerates the inflammatory process by regulating inflammatory cytokine secretion and M1\/M2 macrophage ratio in psoriasis","volume":"197","author":"Zhang","year":"2016","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2018.01.017_bb0130","doi-asserted-by":"crossref","DOI":"10.1038\/cmi.2016.59","article-title":"Mesenchymal stem cells ameliorate B-cell-mediated immune responses and increase IL-10-expressing regulatory B cells in an EBI3-dependent manner","author":"Cho","year":"2017","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.autrev.2018.01.017_bb0135","first-page":"2973","article-title":"Lower level of IL 35 and its reduced inhibition in Th17 cells in patients with bone marrow mononuclear cells coombs test positive hemocytopenia","volume":"17","author":"Li","year":"2018","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.autrev.2018.01.017_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2017.07.041","article-title":"Role of the IL-12\/IL-35 balance in patients with Sj\u00f6gren syndrome","author":"Fogel","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.autrev.2018.01.017_bb0145","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.2337\/dc16-2121","article-title":"Increased interleukin-35 levels in patients with type 1 diabetes with remaining C-peptide","volume":"40","author":"Espes","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.autrev.2018.01.017_bb0150","doi-asserted-by":"crossref","DOI":"10.1038\/srep12633","article-title":"Interleukin-35 administration counteracts established murine type 1 diabetes\u2013possible involvement of regulatory T cells","volume":"5","author":"Singh","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.autrev.2018.01.017_bb0155","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3389\/fimmu.2017.00200","article-title":"Cytokine signatures in mucocutaneous and ocular Beh\u00e7et's disease","volume":"8","author":"Lopalco","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2018.01.017_bb0160","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s12031-014-0443-z","article-title":"Circulating levels of interleukin-35 in patients with multiple sclerosis: evaluation of the influences of FOXP3 gene polymorphism and treatment program","volume":"55","author":"Jafarzadeh","year":"2015","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.autrev.2018.01.017_bb0165","doi-asserted-by":"crossref","first-page":"136329","DOI":"10.1155\/2014\/136329","article-title":"The possible role of the novel cytokines il-35 and il-37 in inflammatory bowel disease","volume":"2014","author":"Li","year":"2014","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.autrev.2018.01.017_bb0170","article-title":"Synoviocytes-derived interleukin 35 potentiates B cell response in patients with osteoarthritis and rheumatoid arthritis","author":"Kam","year":"2017","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2018.01.017_bb0175","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1620\/tjem.237.77","article-title":"Low serum levels of interleukin 35 in patients with rheumatoid arthritis","volume":"237","author":"Ning","year":"2015","journal-title":"Tohoku J Exp Med"},{"key":"10.1016\/j.autrev.2018.01.017_bb0180","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1093\/rheumatology\/keu528","article-title":"Immunoregulatory role of IL-35 in T cells of patients with rheumatoid arthritis","volume":"54","author":"Nakano","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2018.01.017_bb0185","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.cyto.2015.01.019","article-title":"Pro-inflammatory effects of interleukin-35 in rheumatoid arthritis","volume":"73","author":"Filkov\u00e1","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.autrev.2018.01.017_bb0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0132674","article-title":"Interleukin 35 synovial fluid levels are associated with disease activity of rheumatoid arthritis","volume":"10","author":"\u0160enolt","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2018.01.017_bb0195","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1007\/s10067-016-3347-1","article-title":"The clinical utility of serum IL-35 in patients with polymyositis and dermatomyositis","volume":"35","author":"Yin","year":"2016","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2018.01.017_bb0200","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1007\/s10067-015-3006-y","article-title":"Increased IL-35 serum levels in systemic sclerosis and association with pulmonary interstitial involvement","volume":"34","author":"Dantas","year":"2015","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2018.01.017_bb0205","first-page":"2273","article-title":"Interleukin-35 is upregulated in systemic sclerosis and its serum levels are associated with early disease","volume":"54","author":"Tomcik","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2018.01.017_bb0210","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1046\/j.1365-2249.2000.01095.x","article-title":"The role of IL-12 in inflammatory activity of patients with rheumatoid arthritis (RA)","volume":"119","author":"Kim","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2018.01.017_bb0215","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1136\/ard.2009.107649","article-title":"Systemic levels of IL-23 are strongly associated with disease activity in rheumatoid arthritis but not spondyloarthritis","volume":"69","author":"Melis","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2018.01.017_bb0220","doi-asserted-by":"crossref","first-page":"R129","DOI":"10.1186\/ar3067","article-title":"Effects of inflammatory cytokine IL-27 on the activation of fibroblast-like synoviocytes in rheumatoid arthritis","volume":"12","author":"Wong","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2018.01.017_bb0225","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/MAJ.0000000000000215","article-title":"Decreased interleukin 35 and CD4+EBI3+ T cells in patients with active systemic lupus erythematosus","volume":"348","author":"Ouyang","year":"2014","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.autrev.2018.01.017_bb0230","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1177\/0961203315585815","article-title":"Aberrant expression of regulatory cytokine IL-35 in patients with systemic lupus erythematosus","volume":"24","author":"Cai","year":"2015","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2018.01.017_bb0235","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1177\/0961203313498799","article-title":"Glucocorticoid downregulates expression of IL-12 family cytokines in systemic lupus erythematosus patients","volume":"22","author":"Qiu","year":"2013","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2018.01.017_bb0240","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/nature06306","article-title":"The inhibitory cytokine IL-35 contributes to regulatory T-cell function","volume":"450","author":"Collison","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2018.01.017_bb0245","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nri2343","article-title":"How regulatory T cells work","volume":"8","author":"Vignali","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2018.01.017_bb0250","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1016\/j.jid.2017.07.843","article-title":"The unknown aspect of BAFF: inducing IL-35 production by a CD5+CD1dhiFc\u03b3RIIbhi regulatory B-cell subset in lupus","volume":"137","author":"Zhang","year":"2017","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2018.01.017_bb0255","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/cei.12639","article-title":"Remission of systemic lupus erythematosus disease activity with regulatory cytokine interleukin (IL)-35 in Murphy Roths Large (MRL)\/lpr mice","volume":"181","author":"Cai","year":"2015","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2018.01.017_bb0260","doi-asserted-by":"crossref","DOI":"10.1038\/srep12633","article-title":"Interleukin-35 administration counteracts established murine type 1 diabetes\u2013possible involvement of regulatory T cells","volume":"5","author":"Singh","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.autrev.2018.01.017_bb0265","doi-asserted-by":"crossref","DOI":"10.1002\/0471142735.im1509s24","article-title":"The NOD mouse: a model for insulin-dependent diabetes mellitus","author":"Leiter","year":"2001","journal-title":"Curr Protoc Immunol"},{"key":"10.1016\/j.autrev.2018.01.017_bb0270","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.2337\/db11-0784","article-title":"Prevention of autoimmune diabetes by ectopic pancreatic \u03b2-cell expression of interleukin-35","volume":"61","author":"Bettini","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.autrev.2018.01.017_bb0275","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/eji.201646493","article-title":"\u03b2-cell-specific IL-35 therapy suppresses ongoing autoimmune diabetes in NOD mice","volume":"47","author":"Manzoor","year":"2017","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2018.01.017_bb0280","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1089\/dna.2016.3570","article-title":"Interleukin 35 rescues regulatory B cell function, but the effect is dysregulated in ulcerative colitis","volume":"36","author":"Wang","year":"2017","journal-title":"DNA Cell Biol"},{"key":"10.1016\/j.autrev.2018.01.017_bb0285","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/nature12979","article-title":"IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases","volume":"507","author":"Shen","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2018.01.017_bb0290","doi-asserted-by":"crossref","first-page":"5263","DOI":"10.4049\/jimmunol.0902464","article-title":"Skin inflammation induced by the synergistic action of IL-17A, IL-22, oncostatin M, IL-1\u03b1, and TNF-\u03b1 recapitulates some features of psoriasis","volume":"184","author":"Guilloteau","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2018.01.017_bb0295","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.4049\/jimmunol.1600446","article-title":"IL-35 decelerates the inflammatory process by regulating inflammatory cytokine secretion and M1\/M2 macrophage ratio in psoriasis","volume":"197","author":"Zhang","year":"2016","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2018.01.017_bb0300","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1172\/JCI115836","article-title":"A T cell-dependent experimental liver injury in mice inducible by concanavalin A","volume":"90","author":"Tiegs","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2018.01.017_bb0305","article-title":"Interleukin-35 gene-modified mesenchymal stem cells protect concanavalin A-induced fulminant hepatitis by decreasing the interferon gamma level","author":"Wang","year":"2017","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.autrev.2018.01.017_bb0310","first-page":"557","article-title":"Angiogenesis in rheumatoid arthritis","volume":"21","author":"Maruotti","year":"2006","journal-title":"Histol Histopathol"},{"key":"10.1016\/j.autrev.2018.01.017_bb0315","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1159\/000453165","article-title":"IL-35 inhibits angiogenesis through VEGF\/Ang2\/Tie2 pathway in rheumatoid arthritis","volume":"40","author":"Jiang","year":"2016","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.autrev.2018.01.017_bb0320","first-page":"223","article-title":"Interleukin-35 inhibits angiogenesis through STAT1 signalling in rheumatoid synoviocytes","volume":"36","author":"Wu","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2018.01.017_bb0325","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.intimp.2016.02.018","article-title":"Interleukin-35 attenuates collagen-induced arthritis through suppression of vascular endothelial growth factor and its receptors","volume":"34","author":"Wu","year":"2016","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.autrev.2018.01.017_bb0330","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1007\/s00198-015-3410-9","article-title":"Interleukin-35 upregulates OPG and inhibits RANKL in mice with collagen-induced arthritis and fibroblast-like synoviocytes","volume":"27","author":"Li","year":"2016","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.autrev.2018.01.017_bb0335","doi-asserted-by":"crossref","first-page":"7144","DOI":"10.4049\/jimmunol.0902739","article-title":"IL-35 stimulation of CD39+ regulatory T cells confers protection against collagen II-induced arthritis via the production of IL-10","volume":"184","author":"Kochetkova","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2018.01.017_bb0340","doi-asserted-by":"crossref","first-page":"440","DOI":"10.2353\/ajpath.2009.080752","article-title":"Epstein-Barr virus-induced gene-3 is expressed in human atheroma plaques","volume":"175","author":"Kempe","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2018.01.017_bb0345","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1182\/blood-2005-06-2416","article-title":"Interferon regulatory factor 3 is involved in Toll-like receptor 4 (TLR4)- and TLR3-induced IL-12p35 gene activation","volume":"107","author":"Goriely","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2018.01.017_bb0350","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.4049\/jimmunol.174.5.2814","article-title":"EBV-induced gene 3 transcription is induced by TLR signaling in primary dendritic cells via NF-kappa B activation","volume":"174","author":"Wirtz","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2018.01.017_bb0355","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1007\/s10753-017-0582-9","article-title":"IL-35 pretreatment alleviates lipopolysaccharide-induced acute kidney injury in mice by inhibiting NF-\u03baB activation","volume":"40","author":"Hu","year":"2017","journal-title":"Inflammation"},{"key":"10.1016\/j.autrev.2018.01.017_bb0360","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1053\/j.gastro.2011.07.040","article-title":"Interleukin-35 mediates mucosal immune responses that protect against T-cell-dependent colitis","volume":"141","author":"Wirtz","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2018.01.017_bb0365","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1111\/jcmm.13428","article-title":"IL-35 recombinant protein reverses inflammatory bowel disease and psoriasis through regulation of inflammatory cytokines and immune cells","volume":"22","author":"Wang","year":"2018","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.autrev.2018.01.017_bb0370","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/s11033-016-4034-7","article-title":"Interleukin-35 (IL-35) inhibits proliferation and promotes apoptosis of fibroblast-like synoviocytes isolated from mice with collagen-induced arthritis","volume":"43","author":"Li","year":"2016","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.autrev.2018.01.017_bb0375","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.cyto.2016.03.010","article-title":"The effect of interleukins 27 and 35 and their role on mediating the action of insulin like growth factor-1 on the inflammation and blood flow of chronically inflamed rat knee joint","volume":"81","author":"Houshmandi","year":"2016","journal-title":"Cytokine"},{"key":"10.1016\/j.autrev.2018.01.017_bb0380","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1128\/CVI.00052-11","article-title":"Interleukin-35 enhances Lyme arthritis in Borrelia-vaccinated and -infected mice","volume":"18","author":"Kuo","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.autrev.2018.01.017_bb0385","article-title":"Glucocorticoid hormone treatment enhances the cytokine production of regulatory T cells by upregulation of Foxp3 expression","author":"Ugor","year":"2017","journal-title":"Immunobiology"},{"key":"10.1016\/j.autrev.2018.01.017_bb0390","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.autrev.2015.08.006","article-title":"Insights into IL-37, the role in autoimmune diseases","volume":"14","author":"Xu","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2018.01.017_bb0395","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.autrev.2017.05.016","article-title":"Survivin in autoimmune diseases","volume":"16","author":"Gravina","year":"2017","journal-title":"Autoimmun Rev"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156899721830106X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156899721830106X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T09:09:47Z","timestamp":1720256987000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156899721830106X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":79,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S156899721830106X"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2018.01.017","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emerging role of IL-35 in inflammatory autoimmune diseases","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2018.01.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}